Biechele Royce Advisors Edwards Lifesciences Corp Transaction History

Biechele Royce Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $0 - $0	0 New	0 $0
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $137,967 - $204,590	-1,595 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $1,529 - $1,925	15 Added 0.95%	1,595 $187,000
Q4 2021 Feb 09, 2022	BUY	$106.37 - $130.68 $168,064 - $206,474	1,580 New	1,580 $205,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Biechele Royce Advisors, based on Form 13F filings with the SEC.

Stay updated on Biechele Royce Advisors with notifications on news.